PharmaResources (Shanghai) Co., Ltd

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: CNE1000065Q9
CNY
36.90
1.93 (5.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
PharmaResources (Shanghai) Co., Ltd

Why is PharmaResources (Shanghai) Co., Ltd ?

1
With a growth in Net Sales of 28.81%, the company declared Outstanding results in Sep 25
  • OPERATING CASH FLOW(Y) Highest at CNY 140.24 MM
  • NET PROFIT(Q) At CNY 8.11 MM has Grown at 278.24%
  • ROCE(HY) Highest at 3.53%
2
With ROE of 1.68%, it has a fair valuation with a 4.50 Price to Book Value
  • Over the past year, while the stock has generated a return of 16.81%, its profits have risen by 48.6%
  • At the current price, the company has a high dividend yield of 0.2
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to PharmaResources (Shanghai) Co., Ltd should be less than 10%
  2. Overall Portfolio exposure to Miscellaneous should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is PharmaResources (Shanghai) Co., Ltd for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
PharmaResources (Shanghai) Co., Ltd
16.81%
0.91
65.88%
China Shanghai Composite
16.01%
1.07
14.97%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
14.50%
EBIT Growth (5y)
-25.59%
EBIT to Interest (avg)
10.31
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.49
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
348.46%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.27%
ROE (avg)
3.33%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
269
Industry P/E
Price to Book Value
4.50
EV to EBIT
557.94
EV to EBITDA
45.66
EV to Capital Employed
5.84
EV to Sales
7.12
PEG Ratio
NA
Dividend Yield
0.22%
ROCE (Latest)
1.05%
ROE (Latest)
1.68%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

24What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 140.24 MM

NET PROFIT(Q)

At CNY 8.11 MM has Grown at 278.24%

ROCE(HY)

Highest at 3.53%

PRE-TAX PROFIT(Q)

At CNY 7.27 MM has Grown at 191.76%

RAW MATERIAL COST(Y)

Fallen by -81.28% (YoY

NET SALES(Q)

At CNY 161.24 MM has Grown at 28.81%

-6What is not working for the Company
DEBT-EQUITY RATIO (HY)

Highest at -12.42 %

INTEREST COVERAGE RATIO(Q)

Lowest at 426.5

OPERATING PROFIT(Q)

Lowest at CNY 8.69 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 5.39 %

Here's what is working for PharmaResources (Shanghai) Co., Ltd

Net Profit
At CNY 8.11 MM has Grown at 278.24%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Cash Flow
Highest at CNY 140.24 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Pre-Tax Profit
At CNY 7.27 MM has Grown at 191.76%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Sales
At CNY 161.24 MM has Grown at 28.81%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Raw Material Cost
Fallen by -81.28% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for PharmaResources (Shanghai) Co., Ltd

Interest Coverage Ratio
Lowest at 426.5
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio
Highest at -12.42 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Profit
Lowest at CNY 8.69 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 5.39 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales